Fate Therapeutics logo
Healthcare & Life Sciences

Fate Therapeutics

Fate Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series B, 1 tracked investor.

Activeseries-b
series-b
Stage
1
Investors

About Fate Therapeutics

Fate Therapeutics is a startup based in the United States. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.

Fate Therapeutics is a clinical-stage biopharmaceutical company developing induced pluripotent stem cell (iPSC)-derived, off-the-shelf cellular immunotherapies, including engineered natural killer (NK) and T cell products, to treat cancer and immune disorders.

Explore Fate Therapeutics's full profile on Brouky

Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.

Other Startups in United States